TEPP-46, a small molecule PKM2 activator that induces PKM2 tetramerization and blocks PKM2 nuclear translocation, can inhibit the proliferation of Th1 and Th17 cells, reduce the severity of encephalomyelitis, and reverse lactate-induced IL-17 production [177]. Here, IL17A is linked to encephalomyelitis.